Corcept Therapeutics Incorporated Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (26)

Latest Posts

About This Stock More About This Stock
E Corcept Therapeutics: Discounted Biotech Company Offers Exceptional Risk Profile And Lucrative Proprietary Pipeline
Article By: Andrew Roberts
Tuesday, January 22, 2019 3:08 AM EDT
Corcept is a rare low-risk/high-reward investment opportunity in the Biotechnology industry. Total 2018 revenues of $250-270 million represent 90% CAGR over the past 5 years. DCF and comp analysis indicate shares are currently discounted by 35%.
In this article: CORT Also: TEVA
Read
Stocks To Trade: EVTC, CORT, OI
Article By: Ryan Mallory
Friday, January 5, 2018 4:11 AM EDT
Friday's stock picks: Evertec, Corcept Therapeutics and Owens Illinois.
In this article: OI, CORT, EVTC
Read
5 Stocks That Doubled In 2017 And Can Keep Soaring Higher
Article By: Zacks Investment Research
Friday, November 10, 2017 4:31 AM EDT
U.S. stock markets are now hitting all-time highs on a daily basis. Stocks have mostly rallied since last year’s election, with a booming U.S. economy, supportive monetary policy and robust corporate earnings being the key triggers.
In this article: CORT, UCTT, RH, MTOR, MU
Read
4 Biotech Stocks That Show Promise On Sustainable Growth
Article By: Zacks Investment Research
Friday, September 15, 2017 7:20 AM EDT
Within the Medical sector, biotech stocks have performed well in the first half of the year, despite challenges like rising competition, pipeline setbacks, slowdown in growth of mature products and generic competition for certain key drugs.
In this article: SGMO, CORT, HSKA, HLUYY Also: LLY, ALXN, GILD, KITE
Read
Corcept Therapeutics - Chart Of The Day
Article By: Jim Van Meerten
Monday, March 13, 2017 7:12 PM EDT
Chart of the day is: Corcept Therapeutics Incorporated, a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.
In this article: CORT
Read

PARTNER HEADLINES

Latest Tweets for $CORT

No tweets yet!